Ascension To Buy Out CHS’ Stake In Texas Hospital For $460M

/in , /by

CHS and Ascension unveiled the latest deal as hospital mergers and acquisitions are generally trending down amid market volatility.

Read more

Federal Funding Cuts Pose Challenges For Life Sciences Real Estate

/in , /by

According to Savills Research and Data Services’ Q1 U.S. Life Sciences Market Overview, proposed cuts to National Institutes of Health funding could significantly impact demand for life sciences real estate. A suggested 15% cap on indirect costs would limit support for facilities and administrative expenses, potentially forcing research institutions to downsize and startups to halt or slow operations.

Read more